Primary Intranodal Epithelioid Hemangioendothelioma with Molecular Confirmation

Epithelioid hemangioendothelioma (EHE) is a rare low-grade malignant vascular tumor with indolent biology, characterized by reciprocal t(1;3)(p36.6;q25) with resultant WWTR1::CAMTA1 gene fusion in the vast majority of cases, regardless of anatomic location. Only a small subset, exhibiting well formed vasoformative features will contain YAP1::TFE3 gene fusion. Primary intranodal EHE is exquisitely rare. We report a case in a 54-year-old male with persistent left groin mass with discomfort for nine months. A CT of the abdomen and pelvis showed a minimally enlarged left inguinal lymph node measuring 2.8 cm with no other masses or lymphadenopathy. PET/CT and MRI imaging of the abdomen showed no evidence of disease elsewhere. Sections showed an epithelioid vasoformative neoplasm, centrally necrotic and involving a lymph node. The cells were arranged in anastomosing cords with intracytoplasmic lumens, resembling “signet ring cells". By immunohistochemistry, the tumor cells were positive for vimentin, CD31, CD34, ERG and CAMTA1; and negative for AE1/3, CAM 5.2, KRT7, KRT20, desmin, actin, HMB-45 and S-100. Ki-67 proliferation index was estimated at <1%. Molecular studies including next generation sequencing (NGS) revealed the presence of WWTR1 :: CAMTA1 gene fusion, and fluorescence in situ hybridization for CAMTA1 (1p36.23) and WWTR1 (3p25.1) showed fusion signals, diagnostic of EHE. We highlight a rare occurrence of EHE in a lymph node exhibiting morphologic mimicry with metastatic carcinoma.

[1]  C. Fletcher,et al.  Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms , 2021, Modern Pathology.

[2]  L. Doyle,et al.  Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours , 2021, Histopathology.

[3]  Y. Yatabe,et al.  Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases , 2021, The American journal of surgical pathology.

[4]  C. Antonescu,et al.  Variant WWTR1 gene fusions in epithelioid hemangioendothelioma—A genetic subset associated with cardiac involvement , 2020, Genes, chromosomes & cancer.

[5]  Narasimhan P. Agaram,et al.  Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets , 2019, Modern Pathology.

[6]  J. Hornick,et al.  Diagnostic Immunohistochemistry for Soft Tissue and Bone Tumors: An Update , 2018, Advances in anatomic pathology.

[7]  C. Fletcher,et al.  Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics , 2016, The American journal of surgical pathology.

[8]  J. Clarke,et al.  YAP1-TFE3 epithelioid hemangioendothelioma: a case without vasoformation and a new transcript variant , 2015, Virchows Archiv.

[9]  M. F. Petruzzelli,et al.  Epithelioid Hemangioendothelioma: An Overview and Update on a Rare Vascular Tumor , 2014, Oncology reviews.

[10]  J. V. van Gorp,et al.  Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases , 2014, Diagnostic Pathology.

[11]  M. Rubin,et al.  Novel YAP1‐TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma , 2013, Genes, chromosomes & cancer.

[12]  I. Świątkiewicz,et al.  Specificity and sensitivity of INI-1 labeling in epithelioid sarcoma. Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma. , 2012, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[13]  H. Domínguez-Malagón,et al.  Multicentric epithelioid hemangioendothelioma of bone. Report of a case with radiologic-pathologic correlation. , 2012, Annals of diagnostic pathology.

[14]  R. Murali,et al.  Cytologic features of epithelioid hemangioendothelioma. , 2011, American journal of clinical pathology.

[15]  C. Antonescu,et al.  A novel WWTR1‐CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites , 2011, Genes, chromosomes & cancer.

[16]  R. O'Donnell,et al.  Utility of immunohistochemistry for endothelial markers in distinguishing epithelioid hemangioendothelioma from carcinoma metastatic to bone. , 2009, Archives of pathology & laboratory medicine.

[17]  A. Montag,et al.  Epithelioid Hemangioendothelioma of Soft Tissue: A Proposal for Risk Stratification Based on 49 Cases , 2008, The American journal of surgical pathology.

[18]  H. Itoh,et al.  Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression. , 1998, The European respiratory journal.

[19]  Evans,et al.  Epithelioid haemangioendothelioma of the thyroid gland: a case report and review of literature , 1998, Histopathology.

[20]  C. Fletcher,et al.  Primary Vascular Tumors of Lymph Nodes Other Than Kaposi's Sarcoma: Analysis of 39 Cases and Delineation of Two New Entities , 1992, The American journal of surgical pathology.

[21]  T. Lobe,et al.  Epithelioid hemangioendothelioma of the lung (intravascular bronchioloalveolar tumor) in a young girl , 1991, Pediatric pulmonology.

[22]  K. Ishak,et al.  Epithelioid hemangioendothelioma and related lesions. , 1986, Seminars in diagnostic pathology.

[23]  S. Weiss,et al.  Epithelioid hemangioendothelioma a vascular tumor often mistaken for a carcinoma , 1982, Cancer.

[24]  D. Tashkin,et al.  Intravascular bronchioloalveolar tumor. , 1981, The American review of respiratory disease.